HEATHER SIEMINKEWICZ: Open Payments
NPI 1558770701 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,024 in 120 payments from 14 companies in 2025. Trend: 2023 $777 · 2024 $1,431 · 2025 $2,024
Food & beverage: $2,024
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $362 |
| Galderma Laboratories, L.P. | 23 | $346 |
| Novartis Pharmaceuticals Corporation | 16 | $243 |
| GENZYME CORPORATION | 8 | $240 |
| Amgen Inc. | 12 | $200 |
| LEO Pharma Inc. | 7 | $161 |
| Janssen Biotech, Inc. | 13 | $147 |
| Lilly USA, LLC | 5 | $88 |
| Smith+Nephew, Inc. | 2 | $65 |
| Incyte Corporation | 3 | $64 |
Products named: NEMLUVIO, DUPIXENT, Otezla, SKYRIZI, RINVOQ, TREMFYA, SPEVIGO, COSENTYX.
Industry payments across PA — which companies pay providers there.
